For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition time
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: This study is an assessment of the impact of acquisition times on SUV with [(18)F]FDG-PET/CT on healthy livers (reference organ with stable uptake over time) and on tumors. METHODS: One hundred six [(18)F]FDG-PET/CT were acquired in list mode over a single-bed position (livers (n = 48) or on tumors (n = 58)). Six independent datasets of different durations were reconstructed (from 1.5 to 10 min). SUVmax (hottest voxel), SUVpeak (maximum average SUV within a 1-cm(3) spherical volume), and SUVaverage were measured within a 3-cm-diameter volume of interest (VOI) in the right lobe of the liver. For [(18)F]FDG avid tumors (SUVmax ≥ 5), the SUVmax, SUVpeak, and SUV41% (isocontour threshold method) were computed. RESULTS: For tumors, SUVpeak values did not vary with acquisition time. SUVmax displayed significant differences between 1.5- and 5-10-min reconstruction times. SUV41% was the most time-dependent parameter. For the liver, the SUVaverage was the sole parameter that did not vary over time. CONCLUSIONS: For [(18)F]FDG avid tumors, with short acquisition times, i.e., with new generations of PET systems, the SUVpeak may be more robust than the SUVmax. The SUVaverage over a 3-cm-diameter VOI in the right lobe of the liver appears to be a good method for a robust and reproducible assessment of the hepatic metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is especially true for SUVmean and, to a lesser degree, for SUVpeak, which are both relatively stable even after reduction of acquisition time to 50% or less [76,77,78,79,80].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [80]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In contrast, SUVmax can vary substantially because this is, by definition, the outlier, which is most affected by increasing relative errors with declining count statistics [76,80].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777 · cited 9×
“For the liver, a 14-cm3 VOI was positioned on the right lobe of the liver on R10, as proposed in PERCIST [3].”
BackgroundMethodInfluentialFDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2961-x · Cited by 3,303 · cited 2×
“A threshold of 41 % was chosen following the EANM guidelines [10] and because the most common thresholding value chosen in the clinical setting is 40–43 % of the SUVmax.”
MethodQuantitation in Positron Emission Computed Tomography: 1. Effect of Object Size
Hoffman, E. J., Huang, S.-C., & Phelps, M. E. (1979) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-197906000-00001 · Cited by 1,143 · cited 3×
“Moreover, for small lesions or during an effective treatment with a decrease in tumor size, when partial-volume effect may result in an underestimation of [18F]FDG uptake, SUVmax may be best suited as metabolic index than the other SUVs [12].”
BackgroundInfluentialStandards for PET Image Acquisition and Quantitative Data Analysis
Boellaard, R. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057182 · Cited by 902 · cited 1×
“5 versus R10) were observed for the same tumor in the same patient, which is obviously unacceptable for response-monitoring purposes, particularly when accumulated to other sources of bias [11, 21] and if a threshold value is applied to determine treatment response as with PERCIST criteria [3].”
(2004) · PubMed · Cited by 653
Lin, C., Itti, E., Haioun, C., Petegnief, Y., Luciani, A., Dupuis, J., Paone, G., Talbot, J.-N., Rahmouni, A., & Meignan, M. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.042093 · Cited by 394 · cited 2×
“In a clinical point of view, identification of a suitable SUV for response quantification requires clinical trials with patients’ clinical outcomes, and SUVmax demonstrated positive predictive values and accuracies for outcome prediction in lymphoma [1] as well as in solid tumors [13, 14].”
BackgroundWesterterp, M., Pruim, J., Oyen, W., Hoekstra, O., Paans, A., Visser, E., van Lanschot, J., Sloof, G., & Boellaard, R. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0224-1 · Cited by 294 · cited 1×
“SUVpeak has a larger volume compared to the single pixel value of SUVmax and thus should be less affected by image noise [4, 5, 16].”
BackgroundKrak, N. C., Boellaard, R., Hoekstra, O. S., Twisk, J. W. R., Hoekstra, C. J., & Lammertsma, A. A. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1566-1 · Cited by 283 · cited 4×
“Because this VOI encompasses several pixels, SUVpeak is assumed to be less affected by image noise than SUVmax [4, 5] and then more reliable and * Correspondence: av.”
BackgroundMethodInfluentialNoise Considerations for PET Quantification Using Maximum and Peak Standardized Uptake Value
Lodge, M. A., Chaudhry, M. A., & Wahl, R. L. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.101733 · Cited by 226
Nahmias, C., & Wahl, L. M. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.054239 · Cited by 200 · cited 2×
“Because this VOI encompasses several pixels, SUVpeak is assumed to be less affected by image noise than SUVmax [4, 5] and then more reliable and * Correspondence: av.”
Background
Cited by
Alberts, I., Hünermund, J.-N., Prenosil, G., Mingels, C., Bohn, K. P., Viscione, M., Sari, H., Vollnberg, B., Shi, K., Afshar-Oromieh, A., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05282-7 · Cited by 286
“Peak lesion activity and SUVpeak was used to evaluate target lesions, and this parameter has been shown to be less sensitive to acquisition time than SUVmax [15].”
MethodRadiomics in Oncological PET/CT: a Methodological Overview
Ha, S., Choi, H., Paeng, J. C., & Cheon, G. J. (2019) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-019-00571-4 · Cited by 137
Altazi, B. A., Zhang, G. G., Fernandez, D. C., Montejo, M. E., Hunt, D., Werner, J., Biagioli, M. C., & Moros, E. G. (2017) · Journal of Applied Clinical Medical Physics · doi:10.1002/acm2.12170 · Cited by 122
EANM practice guideline for quantitative SPECT-CT
Dickson, J. C., Armstrong, I. S., Gabiña, P. M., Denis-Bacelar, A. M., Krizsan, A. K., Gear, J. I., WYNGAERT, T. V. D., de Geus‐Oei, L., & Herrmann, K. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-06028-9 · Cited by 141
“SUVpeak is an alternative measure for quantitative SPECT, capturing the status of metabolically active features while mitigating image noise [14, 15].”
BackgroundEvolutionary dynamics at the tumor edge reveal metabolic imaging biomarkers
Jiménez-Sánchez, J., Bosque, J. J., Londoño, G. A. J., Molina-García, D., Martínez, Á., Pérez-Beteta, J., Ortega-Sabater, C., Martínez, A. F. H., Vicente, A. M. G., Calvo, G. F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2018110118 · Cited by 71
“We could also have used SUVpeak (the maximum SUV appearing in the distribution when all of the voxels are averaged with their 26 neighbors), which is thought to be more stable and to better define an extended region of high uptake (38).”
Method
Metadata
- Authors
- Sher, A., Lacoeuille, F., Fosse, P., Vervueren, L., Cahouet-Vannier, A., Dabli, D., Bouchet, F., & Couturier, O.
- Affiliations
- Centre Hospitalier Universitaire d'Angers (FR)
- Inserm (FR)
- Corresponding author
- Sher, Avigaëlle
- Venue
- EJNMMI Research
- Published
- 2016-03-05
- Volume
- 6
- Issue
- 1
- Pages
- 21-21
- ISSN
- 2191-219X (ISSN-L)
- PMC
- PMC4779086
- OpenAlex
- W2292171573
- Cited by
- 111
- References
- 24
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 13 · 2023: 23 · 2022: 15 · 2021: 16 · 2020: 8 · 2019: 12 · 2018: 6 · 2017: 5 · 2016: 1
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- EJNMMI Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Keywords
- 18F-FDG PET/CT, SUVpeak, SUVmax, acquisition time, list-mode acquisition, liver SUV, tumor quantification, hepatic glucose metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition time. https://app.cochat.ai/papers/10.1186/s13550-016-0177-8
- The paper
- Sher, A., Lacoeuille, F., Fosse, P., Vervueren, L., Cahouet-Vannier, A., Dabli, D., Bouchet, F., & Couturier, O. (2016). For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition time. EJNMMI Research. https://doi.org/10.1186/s13550-016-0177-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.